Bydureon combined with Lantus

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Injection Site Haemorrhage Other Serious 2/3/2012 Male 2/15/2012 Consumer Ireland
Primary
Concomitant
Blood Glucose Increased Hospitalization 2/1/2012 51 Female 3/15/2012 Consumer Germany
Primary
Concomitant
Off Label Use Other Serious 4/4/2012 53 Female 215 lb 5/3/2012 Consumer United States
Primary
Concomitant
Injection Site Nodule Other Serious 4/23/2012 42 Female 165 lb 5/23/2012 Consumer United States
Primary
Concomitant
Off Label Use Other Serious 4/20/2012 62 Female 182 lb 5/25/2012 Consumer United States
Primary
Concomitant
Off Label Use Death 4/2/2012 70 Female 6/19/2012 Consumer Finland
Primary
Concomitant
Injection Site Nodule Other Serious 4/23/2012 42 Female 165 lb 6/27/2012 Consumer United States
Primary
Concomitant
Rash Pruritic Other Serious 5/10/2012 34 Male 6/29/2012 Consumer United States
Primary
Concomitant
Injection Site Haematoma Hospitalization 2/1/2012 65 Female 263 lb 7/13/2012 Consumer United States
Primary
Concomitant
Dysphagia Other Serious 8/6/2012 Male 8/21/2012 Consumer Sweden
Primary
Concomitant
Hyperglycaemia Other Serious 8/15/2012 68 Female 8/23/2012 Physician United States
Primary
Concomitant
Vomiting Hospitalization 4/24/2012 56 Male 9/7/2012 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious Male 9/10/2012 Consumer Us
Primary
Concomitant
Weight Increased Other Serious 7/2012 Female 115 lb 12/11/2012 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 8/2012 Male 475 lb 9/27/2012 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 5/2009 Female 11/9/2012 Consumer Us
Primary
Secondary
Concomitant
Pain In Extremity Female 206 lb 10/26/2012 Consumer Us
Primary
Concomitant
Off Label Use Other Serious 10/29/2012 43 Male 11/2/2012 Consumer Us
Primary
Concomitant
Off Label Use Hospitalization 10/2/2012 55 Female 11/1/2012 Consumer Us
Primary
Concomitant
Clostridium Difficile Infection 5/18/2012 38 Female 202 lb 11/8/2012 Other Health Professional Us
Primary
Concomitant
Diabetic Ketoacidosis Hospitalization 11/14/2012 24 Male 11/26/2012 Consumer Us
Primary
Concomitant
Tremor Other Serious 11/28/2012 45 Female 252 lb 1/25/2013 Consumer Us
Primary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 6/21/2012 60 Female 12/5/2012 Physician Us
Primary
Concomitant
Presyncope Other Serious 4/5/2012 57 Female 224 lb 12/14/2012 Consumer Us
Primary
Secondary
Concomitant
Off Label Use Other Serious 8/3/2012 Male 2/4/2013 Consumer De
Primary
Concomitant
Off Label Use Other Serious 1/12/2013 Female 2/28/2013 Other Health Professional Us
Primary
Concomitant
Weight Decreased Other Serious 1/2013 Female 160 lb 2/12/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious Female 185 lb 3/8/2013 Physician Us
Primary
Secondary
Concomitant
Off Label Use Other Serious 1/2013 Female 3/14/2013 Physician Us
Primary
Concomitant
Injection Site Swelling Other Serious Female 2/25/2013 Consumer Us
Primary
Concomitant
Oropharyngeal Pain Other Serious 2/17/2013 74 Female 270 lb 2/28/2013 Consumer Us
Primary
Concomitant
Swelling Face Other Serious 1/2013 Female 175 lb 2/28/2013 Consumer Us
Primary
Concomitant
Palpitations Hospitalization 2/2013 Female 290 lb 3/5/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 10/2012 Male 196 lb 3/8/2013 Consumer Us
Primary
Concomitant
Wound Infection Staphylococcal Other Serious 6/2012 Female 214 lb 3/7/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use Other Serious 1/2013 Female 260 lb 3/15/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 62 Female 185 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use Other Serious Male 285 lb 4/3/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus Other Serious 52 Female 6/6/2013 Consumer Gb
Primary
Secondary
Wound Infection Staphylococcal Hospitalization 6/2012 63 Female 214 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pruritus Other Serious 52 Female 5/30/2013 Other Health Professional Gb
Primary
Secondary
Injection Site Pruritus Other Serious 52 Female 6/19/2013 Other Health Professional Gb
Primary
Secondary
Concomitant
Dizziness Hospitalization 4/15/2013 72 Female 5/10/2013 Consumer Us
Primary
Concomitant
Off Label Use 70 Female 158 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use 1/2013 51 Female 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 2013 55 Female 174 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 10/2012 68 Male 196 lb 6/25/2013 Consumer Us
Primary
Concomitant
Sleep Disorder 2005 74 Male 170 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use 3/4/2013 59 Male 210 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Urticaria 45 Female 5/25/2013 Consumer Us
Primary
Concomitant
Wrong Technique In Drug Usage Process 3/18/2013 48 Female 187 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 3/11/2013 38 Male 5/25/2013 Consumer Us
Primary
Concomitant
Underdose 3/14/2013 58 Male 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 49 Female 226 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus 46 Female 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use Female 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 2/2013 63 Male 5/25/2013 Consumer Us
Primary
Concomitant
Diarrhoea 72 Male 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 2/23/2013 45 Male 11/26/2013 Consumer Us
Primary
Concomitant
Palpitations Other Serious 2/2013 68 Female 5/25/2013 Consumer Us
Primary
Concomitant
Joint Stiffness 60 Male 192 lb 5/25/2013 Consumer Us
Primary
Concomitant
Weight Increased 71 Female 230 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use Female 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased 3/16/2013 68 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Underdose 3/14/2013 58 Male 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 10/27/2012 73 Male 168 lb 5/25/2013 Consumer Us
Primary
Concomitant
Underdose 3/10/2013 63 Female 175 lb 5/25/2013 Consumer Us
Primary
Concomitant
Pancreatitis Acute Other Serious 2012 NotSpecified 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use Other Serious 12/5/2012 73 Male 275 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 3/8/2013 69 Female 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use Other Serious 1/2013 54 Female 260 lb 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased 68 Male 250 lb 5/25/2013 Consumer Us
Primary
Concomitant
Medication Error 48 Female 174 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 1/17/2013 67 Female 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased Female 201 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Overdose 8/2012 68 Male 250 lb 11/26/2013 Consumer Gb
Primary
Secondary
Concomitant
Cerebrovascular Accident Hospitalization 71 Female 180 lb 5/31/2013 Consumer Us
Primary
Concomitant
Gait Disturbance Other Serious 4/2013 61 Male 265 lb 6/18/2013 Consumer Us
Primary
Secondary
Concomitant
Muscle Haemorrhage Hospitalization 5/2013 58 Male 6/26/2013 Physician Us
Primary
Secondary
Concomitant
Post Procedural Complication Other Serious 2012 68 Female 200 lb 7/8/2013 Other Health Professional Us
Primary
Concomitant
Vomiting Other Serious 8/28/2013 57 Female 11/5/2013 Physician Us
Primary
Concomitant
Injection Site Pruritus 70 Male 175 lb 9/27/2013 Consumer Us
Primary
Secondary
Injection Site Pain 4/15/2013 67 Male 182 lb 9/27/2013 Consumer Us
Primary
Secondary
Nausea 60 Male 10/17/2013 Other Health Professional Us
Primary
Secondary
Product Quality Issue 10/8/2013 53 Female 152 lb 10/8/2013 Us
Primary
Concomitant
Pancreatitis Acute Hospitalization 10/28/2013 68 Male 212 lb 11/4/2013 Physician Us
Primary
Concomitant
Adenocarcinoma Of Colon Hospitalization 10/9/2013 62 Male 262 lb 12/27/2013 Physician Us
Primary
Concomitant
Renal Cell Carcinoma Other Serious 8/8/2013 58 Male 302 lb 11/18/2013 Consumer Nl
Primary
Concomitant
Weight Decreased 61 Female 177 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 63 Male 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Haemorrhage 44 Female 160 lb 11/26/2013 Consumer Us
Primary
Secondary
Weight Decreased 7/2013 62 Female 176 lb 11/26/2013 Consumer Us
Primary
Concomitant
Overdose 5/26/2013 66 Male 247 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea 64 Female 270 lb 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 2013 50 Female 11/26/2013 Physician Us
Primary
Secondary
Concomitant
Nausea 53 Female 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 1/2013 73 Female 190 lb 11/26/2013 Consumer Us
Primary
Concomitant
Expired Drug Administered 6/2013 65 Male 274 lb 11/26/2013 Consumer Us
Primary
Concomitant
Wrong Technique In Drug Usage Process 76 Female 180 lb 11/26/2013 Other Health Professional Us
Primary
Concomitant
Weight Decreased 1/2013 78 Female 188 lb 11/26/2013 Consumer Us
Primary
Concomitant
Nausea 62 Female 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 3/7/2013 70 Female 210 lb 11/26/2013 Physician Us
Primary
Concomitant
Vomiting 67 Female 214 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pain 63 Female 122 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pain Other Serious 66 Female 225 lb 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Mass 61 Female 209 lb 11/26/2013 Physician Us
Primary
Secondary
Injection Site Swelling 2013 66 Male 175 lb 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 59 Male 11/26/2013 Consumer Us
Primary
Concomitant
Underdose 3/15/2013 58 Male 350 lb 11/26/2013 Physician Us
Primary
Concomitant
Injection Site Reaction 1/2013 61 Female 175 lb 11/26/2013 Consumer Us
Primary
Secondary
Drug Ineffective 58 Female 11/26/2013 Consumer In
Primary
Concomitant
Weight Decreased 71 Female 212 lb 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Haemorrhage 2013 57 Male 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 50 Female 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage 4/3/2013 51 Female 11/26/2013 Consumer Us
Primary
Secondary
Injection Site Haemorrhage 58 Female 215 lb 11/26/2013 Consumer Us
Primary
Concomitant
Product Quality Issue 64 Female 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 63 Male 148 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Urticaria 73 Male 260 lb 11/26/2013 Consumer Us
Primary
Concomitant
Abdominal Pain Upper Disability 62 Male 215 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage 11/2012 68 Male 290 lb 11/26/2013 Consumer Us
Primary
Concomitant
Product Quality Issue 2013 55 Male 210 lb 11/26/2013 Consumer Us
Primary
Concomitant
Nausea 3/2013 57 Male 11/26/2013 Consumer Us
Primary
Concomitant
Weight Increased Female 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Rash Female 278 lb 11/26/2013 Other Health Professional Us
Primary
Concomitant
Injection Site Nodule 2013 50 Male 243 lb 11/26/2013 Physician Us
Primary
Concomitant
Blood Glucose Increased 4/22/2013 72 Male 222 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Night Sweats 4/2013 34 Male 270 lb 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 7/19/2013 60 Male 11/26/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased Other Serious 5/2/2013 72 Female 232 lb 11/26/2013 Physician Us
Primary
Secondary
Injection Site Pain 68 Female 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Mass 75 Female 148 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Mass 51 Male 11/26/2013 Consumer Us
Primary
Concomitant
Nausea 4/14/2013 66 Female 170 lb 11/26/2013 Other Health Professional Us
Primary
Concomitant
Injection Site Pain 57 Female 11/26/2013 Consumer Us
Primary
Concomitant
Vomiting Other Serious 10/2012 73 Female 200 lb 11/26/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 61 Male 180 lb 11/26/2013 Consumer Us
Primary
Secondary
Weight Decreased 7/2013 74 Male 194 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pain Hospitalization 55 Female 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 77 Female 11/26/2013 Consumer Us
Primary
Secondary
Decreased Appetite 2013 Male 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage Male 11/26/2013 Consumer Us
Primary
Concomitant
Weight Decreased 1/2013 53 Female 173 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage 57 Male 324 lb 11/26/2013 Consumer Us
Primary
Concomitant
Somnolence 8/6/2013 61 Female 260 lb 11/26/2013 Consumer Us
Primary
Secondary
Product Quality Issue 8/6/2013 50 Female 11/26/2013 Physician Us
Primary
Concomitant
Injection Site Extravasation 8/10/2013 69 Female 205 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus 60 Female 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage 8/12/2013 Male 175 lb 11/26/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 63 Female 195 lb 11/26/2013 Consumer Us
Primary
Secondary

Drug Data